 Actinium Pharmaceuticals Inc NYSEAMERICAN:ATNM Investment analysts at William Blair raised their Q2 2020 EPS estimates for Actinium Pharmaceuticals in a research note issued to investors on Tuesday, June 30th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will earn 0.01 per share for the quarter, up from their prior estimate of ... 